The reckless and excessive use of antimicrobials in the agricultural, veterinary and medical sectors contributes to the global epidemic increase in antimicrobial resistance (AMR). According to Samreen et al. (2021), there is growing concern that the environment acts as a reservoir of AMR and plays a key role in the spread of antimicrobial resistance genes (ARGs).
Since antimicrobials used in human and animal health largely comprise the same or very similar molecules, the transmission of resistance between animals and people can occur, either directly or through the environment (Robinson et al. 2016). Thus, adopting the One Health approach to the study of AMR is fundamental. With this premise in mind, we tried to obtain isolates recovered from the three domains of One Health for this study: humans, animals and the environment. However, we did not obtain any from the environment among the S. aureus isolates selected with the desired profile in this study.
Among the selected isolates, there was high resistance (94.1%) to erythromycin, an antimicrobial of the macrolide class (Fig. 1), one of the classes of choice for the treatment of S. aureus infections due to its pharmacokinetic properties and its antimicrobial profile. According to Fiebelkorn et al. (2003), in Staphylococci, macrolide resistance may be due to active efflux (msrA encoded) or ribosomal target modification (macrolide-lincosamide-streptogramin B [MLSB] resistance; usually encoded by ermA or ermC). In our study, only two (5.9%) isolates had the msrA gene. Evidence shows that target modification encoded by ermA, ermB and ermC is the main mechanism in S. aureus for cross-resistance to MLSB antibiotics, including resistance to erythromycin and cross-resistance to lincosamide clindamycin (Sun et al. 2018). Thus, it is believed that the resistance of most of the isolates in the present study was due to target modification, since the percentage of resistance to clindamycin by the isolates was also high (Fig. 1).
As for ciprofloxacin, whose percentage of resistance among the isolates was 76.5%, one of the resistance mechanisms in S. aureus is the presence of efflux pumps (Rajabi et al. 2020) and the MES NorA, NorB and NorC have the ability to expel this fluoroquinolone (Truong-Bolduc et al. 2006a; Bambeke et al. 2010). The detection of the norA, norB and norC genes was 97.1, 76.5 and 100%, respectively, and at least one of these genes was detected in all of the study isolates (Fig. 4), which may explain the high resistance to ciprofloxacin (Fig. 1). Another mechanism that causes fluoroquinolone resistance are mutations that occur in the quinolone resistance-determining region (QRDR) of topoisomerase IV encoded by grlA/grlB and DNA gyrase encoded by gyrA/gyrB; these mutations decrease drug affinity (Hassanzadeh et al. 2017) and may be present in the studied isolates.
In relation to tetracycline, 44.1% of the S. aureus studied showed resistance (Fig. 1). According to Wendlandt et al. (2013), two mechanisms of resistance to tetracyclines were identified among staphylococci: active efflux and ribosomal protection. The MES Tet38 of the MFS family confers, among others, resistance to tetracycline (Truong-Bolduc et al. 2021). NorB is also capable of effluxing tetracyclines (Bambeke et al. 2010). However, as with ciprofloxacin, the use of CCCP was not able to reduce the MIC of tetracycline in any of the isolates evaluated. Thus, ribosomal protection may be the strategy used by these isolates.
Also, in S. aureus, MgrA acts as an indirect regulator of norA, norB, norC and tet38 expression, negatively regulating the transcription of these genes (Truong-Bolduc et al. 2006a). Thus, the difficulty in reducing the MICs of resistant and positive isolates for efflux system genes may have also occurred due to their low transcription, which would imply in few active efflux systems that could be inhibited.
MES LmrS also belongs to the MFS family and has linezolid, chloramphenicol, florfenicol, trimethoprim, erythromycin, kanamycin, fusidic acid, lincomycin, streptomycin, tetraphenylphosphonium and ethidium bromide as substrates. The lmrS gene encoding this protein is located on the bacterial chromosome and was detected in 94.1% of the MDR S. aureus selected for this study (Fig. 4).
Ethidium bromide is a substrate for different SEM; among those researched in the present work, it is effluxed by NorA and LmrS (Hassanzadeh et al. 2017). Comparing their efflux in the presence and absence of CCCP, 55.9% of the isolates exhibited SEM activity. Ethidium bromide is particularly suitable for use as a probe for these studies because it emits weak fluorescence in aqueous solution and becomes strongly fluorescent in nonpolar and hydrophobic environments, especially when it penetrates the bacterial cell wall and accumulates in the cytoplasm (Viveiros et al. 2010).
We are not aware of the use of this tool as a screening tool to detect efflux activity in S. aureus, being most commonly used to compare SEM activity in isolates that are genetically altered to overexpress or knockout SEM genes. There are also reports of its use in comparing emitted fluorescence to determine the activity of new compounds such as EPI (Espinoza et al. 2019; de Sousa Andrade et al. 2020). However, using the efflux of EtBr in our bacterial library allowed us to evidence SEM activity, even when we were not able to do so through the use of MIC, the most traditionally used technique. Therefore, we describe here a new application of the technique that can be used to support traditional techniques for the detection of SEM activity.
To determine the effect of efflux inhibition on biofilm formation, we used CCCP. Compared to the control, the presence of CCCP decreased the biofilm formation of the isolates that had SEM activity (Fig. 3). Decreased S. aureus biofilm formation using CCCP has been reported previously (Baugh et al. 2014; Garrison et al. 2015). The inhibition of biofilm formation was not the result of antibacterial action, since the isolates were able to multiply in the presence of CCCP. Thus, efflux inhibition is a promising antibiofilm strategy.
Regarding the molecular epidemiology of the isolates, the restriction pattern obtained with SmaI submitted to PFGE revealed the existence of eight clusters, with the H cluster being dominant (n=14) and formed only by isolates of human origin with a similarity greater than 90%. Cluster E (n=6) was also formed by only human isolates. Small differences in restriction patterns may be the result of genetic rearrangements that allow the isolates to adapt to the host and increase its pathogenicity. However, three clusters were obtained (C, D and F) where there was a mixture of the origin of isolates. In these, the isolates seem to have evolved in ways that are adapted to the different domains studied: humans, animals and food. New omics studies are needed to better assess this dispersion.
All isolates of human origin were recovered from the same hospital, within an intensive care environment. In view of the great similarity found in the restriction patterns of these isolates, it is believed that they are residents of the environment and capable of causing nosocomial infections. In addition, one can think about the adoption of a sessile way of life (biofilm) by these isolates, which makes it difficult to eliminate them from the environment, even using correct disinfection and asepsis techniques. Medical devices are excellent support for bacterial adhesion and biofilm formation (Ribeiro et al., 2012). The combinational therapies show great potential to biofilm combat, which is reinforced by the inhibitory effect of CCCP among the S. aureus isolates tested in the present work (Kranjec et al., 2021).
Analyzing the food source isolates, the pattern was quite heterogeneous, with the isolates being distributed in five clusters, mixed with other sources or not. This diversity probably reflects the multiple sources of contamination by S. aureus: animals and their raw milk, the processing environment and the personnel involved in the production chain (Loncarevic et al. 2005).
Thus, multidrug-resistant S. aureus isolates from humans, animals and foods carry distinct MES genes, and their activity was detected through ethidium bromide efflux. The inhibition of this activity did not change resistance to the antimicrobials ciprofloxacin and tetracycline, but resulted in a decrease in biofilm formation by these isolates. This may be a strategy adopted in an attempt to reduce nosocomial infections caused by this bacterium, which may remain in the environment through biofilms. Still, S. aureus MDR with active multidrug efflux systems are circulating between One Health domains and it is necessary to think of strategies to decrease this circulation in order to prevent the dissemination of resistance mediated by MES. Finally, we highlight the use of ethidium bromide efflux quantification as a screening tool for the detection of SEM activity in S. aureus.
More studies are needed to determine the prevalence of this mechanism in isolates of environmental origin and to enrich the information on its dispersion. This study brings relevant and unpublished data on the dispersion of S. aureus MDR in the context of One Health.